FDA & Government News

Cataract Surgeons Gain a New Lens Tool

An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.

Share

  • 1

    TECNIS PureSee IOL approved by FDA.

  • 2

    Designed for cataract surgery and addresses presbyopia.

  • 3

    Offers improved intermediate vision with some near capability.

  • 4

    Maintains contrast sensitivity like aspheric monofocal IOLs.

  • 5

    97% of patients reported no major vision disturbances.

  • 6

    2026 US market availability planned.

  • 7

    Includes a toric version for patients with astigmatism.

  • 8

    Used in nearly half a million eyes globally.

Original Source(s)

Cataract Surgeons Gain a New Lens Tool

An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.

  • by Kathryn Wighton

  • March 12, 2026

  • 3 min

Related Content

Beyond IOP: The Mood Effects of CAIs

Evidence from large US dataset suggests topical carbonic Anhydrase Inhibitors may increase depression risk in glaucoma patients

  • March 12, 2026

  • 5 min
The Most Influential Conversations in Ophthalmology Aren’t on the Podium

How WhatsApp is quietly shaping clinical practice

Could Wegovy Raise Optic Nerve Risk?

A pharmacovigilance analysis of FDA adverse event reports finds the strongest ischemic optic neuropathy reporting signal with high-dose semaglutide formulations, with higher adjusted odds reported in men.